Based in the biotech hot spot of San Francisco’s Mission Bay district, Twist Bioscience has developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring silicon platforms capable of producing the basic tools used for synthetic biology, such as oligonucleotides, genes, pathways, and genomes. By synthesizing DNA on silicon instead of on the more costly traditional plastic plates (a 20 year old technology), Twist’s unique silicon platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. The Twist Bioscience platform has the potential for many synthetic DNA applications across the medical & research, agricultural, and industrial industries. Twist’s investors include ARCH Ventures and Paladin Capital Group.
For more information on Twist Bioscience, please visit their web site at http://www.twistbioscience.com/